ArticlePoultry science2026
Dietary potassium diformate improves slaughter performance, systemic metabolic homeostasis, and intestinal health without compromising growth performance in Qingyuan Partridge chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 63-day feeding trial was conducted with 1,800 one-day-old male Qingyuan Partridge chickens, covering three feeding phases: starter (days 1-22), grower (days 23-42) and finisher (days 43-63). Birds were randomly allocated to four dietary treatments with six replicate pens of 75 chickens each: an antibiotic-containing control (ACC), an antibiotic-free control (AFC), and two groups supplemented with 0.45% and 0.60% potassium diformate (KDF), respectively. The evaluated endpoints included phase-specific growth performance, slaughter traits at day 63, routine hematology, serum biochemistry, arterial blood gas profiles, and cecal microbiota characterized via 16S rRNA high-throughput sequencing. Growth and blood indices were analyzed by one-way ANOVA followed by Tukey's post-hoc test, while microbiota data were assessed via PERMANOVA and Kruskal-Wallis rank-sum test. Statistical significance was set at P < 0.05, and 0.05 ≤ P < 0.10 was defined as a statistical trend. Over the entire experimental period, no significant intergroup differences were detected in average daily gain (ADG) or feed conversion ratio (FCR), though 0.60% KDF significantly increased FCR exclusively during the starter phase. The 0.60% KDF group achieved slaughter rate (SR), semi-eviscerated weight ratio (SEWR) and eviscerated weight ratio (EWR) comparable to the antibiotic control, and significantly outperformed the 0.45% KDF group. The AFC group exhibited elevated serum blood urea nitrogen (BUN), uric acid (UA), lactate dehydrogenase (LDH) and creatine kinase (CK), all of which were attenuated by KDF supplementation. The 0.45% KDF group had significantly higher serum carbon dioxide combining power (CO₂CP) and lower chloride (Cl⁻) than both the AFC and ACC groups, while the anion gap (AG) remained unchanged. KDF did not alter cecal microbial alpha diversity but selectively regulated the relative abundance of specific taxa, enriching butyrate-producing genera and suppressing opportunistic pathogens including Gammaproteobacteria. Kyoto Encyclopedia of Genes and Genomes (KEGG) functional prediction revealed that 0.60% KDF downregulated microbiota-mediated infectious disease pathways. Collectively, dietary supplementation with 0.60% KDF was identified as the optimal inclusion level for Qingyuan Partridge Chickens in the present trial. Dietary KDF exerts negligible improvement on overall growth performance but markedly improves core slaughter traits, regulates host metabolism and enriches beneficial cecal microbes. This work provides dosage-specific recommendations and a theoretical basis for KDF application in premium native yellow-feathered broilers in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.